Abstract
Raynaud’s Syndrome (RS) is generally characterized by either ischemic or hyperemic symptoms and is relatively frequent in patients hypersensitive to cold or with emotional stress. This phenomenon usually cease after no more than some minutes, however, can persist for hours Its treatment is aimed at promoting vasodilation i.e., warming procedures. Anxiety control prior to surgical procedure helps in prevention the occurrence of RS. Despite RS following local dental anesthesia being rare, dentists must be prepared to manage. There are limited reports of patients with this syndrome during dental procedures, so here we describe a case of a patient who has undergone a surgical implant installation and who developed primary RS following local anesthesia using an adrenergic vasoconstrictor, as well as the management of this complication in dental office. Dentists should be able to recognize the RS and follow the appropriate guidelines available, after control the case the patient should also be referred to a general physician for further investigations.
Highlights
Described in 1862, Raynaud’s Syndrome (RS) is characterized by episodic ischemia frequently identified in patients hypersensitive to cold or with emotional stress (Milet et al, 1953), (Pope, 2007), (Landry, 2013)
Raynaud's syndrome is characterized by local vasoconstriction and blanching especially in the extremities, which is followed by cyanosis and rebound hyperemia surrounding the affected site (Landry, 2013), (Jackson, 2006) (Kayser et al, 2009)
There are limited reports of patients with this syndrome during dental procedures, so this paper describes the case of a patient schedule for dental implant placement and who developed RS following local anesthesia using an adrenergic vasoconstrictor
Summary
Described in 1862, RS is characterized by episodic ischemia frequently identified in patients hypersensitive to cold or with emotional stress (Milet et al, 1953), (Pope, 2007), (Landry, 2013). Depending on variables such as the population analyzed, climate of the region, and clinical outcome definition, the prevalence of RS worldwide ranges from 0.5% to 20% (Voulgari et al, 2000), (Suter et al, 2005), (De Angelis et al, 2006). There are limited reports of patients with this syndrome during dental procedures, so this paper describes the case of a patient schedule for dental implant placement and who developed RS following local anesthesia using an adrenergic vasoconstrictor
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
